G
Gastrobodytx
Gastrobody Therapeutics develops ultrastable, orally-administered protein therapeutics specifically designed for gastrointestinal tract conditions. These gastrobodies target GI diseases locally, avoiding systemic circulation associated with traditional injectable antibody treatments. This platform offers a patient-centric approach to treating conditions like Inflammatory Bowel Disease (IBD) by ensuring therapeutic stability within the harsh GI environment.
Traction –/10
HQ unknown
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Gastrobody Therapeutics develops ultrastable, orally-administered protein therapeutics specifically designed for gastrointestinal tract conditions. These gastrobodies target GI diseases locally, avoiding systemic circulation associated with traditional injectable antibody treatments. This platform offers a patient-centric approach to treating conditions like Inflammatory Bowel Disease (IBD) by ensuring therapeutic stability within the harsh GI environment.